OriGene Technologies Acquires Beijing Zhongshan Golden Bridge Biotechnology

OriGene Technologies, Inc. announced today the acquisition of Beijing Zhongshan Golden Bridge Biotechnology Co., Ltd (ZsBio).

Founded in the year 1993, ZsBio provides testing products (pathology) within their domestic Chinese market, such as oncology diagnostics.

OriGene had the following to say regarding today’s acquisition, “With its leadership position in the Chinese pathology testing market, ZsBio is the ideal partner for OriGene,” said Wei-Wu He, CEO of OriGene.  “ZsBio is already a leader in pathology products for cancer applications and has a wide range of market-leading diagnostics products used in hospitals and laboratories in China. In turn, OriGene brings to ZsBio innovative highly specific monoclonal antibodies and assays to complement and strengthen ZsBio’s portfolio of products.”

In a market that has experienced double-digit market growth annually, OriGene hopes the acquisition of ZsBio bolsters their bottom-line.

OriGene Technologies, Inc., is a biosciences company dedicated to develop gene centric innovative products and services to improve the quality of healthcare diagnostics and treatments while ZsBio has more than 25 years of pathology diagnostics experience in China.

Latest News

GAM Holding AG Increases Holdings in FLIR Systems, Inc.
GAM Holding AG Increases Holdings in FLIR Systems, Inc.
Loomis Sayles & Co. L P Boosts Holdings in Ciena Co.
Loomis Sayles & Co. L P Boosts Holdings in Ciena Co.
Loomis Sayles & Co. L P Sells 84,276 Shares of Alexion Pharmaceuticals, Inc.
Loomis Sayles & Co. L P Sells 84,276 Shares of Alexion Pharmaceuticals, Inc.
Loomis Sayles & Co. L P Has $6.96 Million Position in Columbia Banking System Inc
Loomis Sayles & Co. L P Has $6.96 Million Position in Columbia Banking System Inc
GAM Holding AG Sells 19,973 Shares of Aircastle Limited
GAM Holding AG Sells 19,973 Shares of Aircastle Limited
Loomis Sayles & Co. L P Grows Holdings in Morningstar, Inc.
Loomis Sayles & Co. L P Grows Holdings in Morningstar, Inc.


© 2006-2018 Ticker Report